Keywords: sanofi-aventis, beats, expectations, 1st-qtr, adjusted, eps, rising
Sanofi-Aventis beats expectations with 1st-qtr adjusted EPS rising 53%
Article | 15 May 2006
Paris, France-headquartered Sanofi-Aventis, Europe's largest drugmaker, has beaten analysts' consensus forecasts, reporting adjusted net income of 2.17 billion euros ($2.74 billion) for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
